Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1861 USD | -10.31% | +1.14% | +27.99% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Mar. 28 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.91M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -59M | EV / Sales 2022 | - |
Net Debt 2022 | 108M | Net Debt 2023 | 134M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-0.11
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.8% |
1 day | +13.57% | ||
1 week | +11.56% | ||
Current month | +48.21% | ||
1 month | -7.37% | ||
3 months | +19.25% | ||
6 months | +11.14% | ||
Current year | +42.71% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis P. Riley
FOU | Founder | - | 08-12-31 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 12-10-31 |
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Michael Powell
CHM | Chairman | 69 | 16-11-27 |
Kevin Lokay
BRD | Director/Board Member | 67 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.1861 | -10.31% | 2 170 162 |
24-04-25 | 0.2075 | +13.57% | 685,757 |
24-04-24 | 0.1827 | -5.82% | 815,454 |
24-04-23 | 0.194 | +1.68% | 355,964 |
24-04-22 | 0.1908 | +3.70% | 676,605 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+42.71% | 11.29M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.82% | 22.02B | |
-17.84% | 20.9B | |
-9.35% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- GRTX Stock